Traditionally, the treatment of patients with Crohn's disease has focused on decreasing symptoms, improving quality of life, and decreasing complications related to either the disease process or ...

In a finding that suggests sooner is better than later, a new trial shows that giving advanced treatment early to Crohn's patients can dramatically improve their gut health. About 80% of those who ...

A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...

Getting advanced treatment immediately after a Crohn’s disease diagnosis improves patient outcomes, according to a year-long ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.

(LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. Omvoh is now approved ...

Inflectra market Report 2025 ... formulation of infliximab for the maintenance treatment of moderately to severely active Crohn's disease CD and ulcerative colitis UC in adults.